ANTIINFLAMMATORY AND ANALGESIC ACTIVITY OF A NONPEPTIDE SUBSTANCE-P RECEPTOR ANTAGONIST

被引:66
作者
NAGAHISA, A [1 ]
KANAI, Y [1 ]
SUGA, O [1 ]
TANIGUCHI, K [1 ]
TSUCHIYA, M [1 ]
LOWE, JA [1 ]
HESS, HJ [1 ]
机构
[1] PFIZER INC,DEPT MED CHEM,DIV LABS & RES,GROTON,CT 06340
关键词
NEUROGENIC INFLAMMATION; PLASMA EXTRAVASATION; SUBSTANCE-P ANTAGONISTS; TACHYKININS; CAPSAICIN; PAIN;
D O I
10.1016/0014-2999(92)90847-W
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
CP-96,345, a potent non-peptide antagonist of the substance P (SP) receptor, inhibited SP-, neurokinin A (NKA)- and neurokinin B-induced plasma extravasation in guinea pig dorsal skin. The inhibition was specific for the three tachykinins; CP-96,345 was not active against plasma leakage caused by histamine, bradykinin, platelet-activating factor or leukotriene D4. CP-96,345 inhibited capsaicin-induced plasma extravasation in the ureter, an inflammatory response caused by neuropeptides released from afferent C-fibers. Thus, the NK1 receptor appears to play a major role in vascular permeability increases induced by exogenous and endogenous tachykinins. In contrast, CP-96,345 was inactive against SP- and NKA-induced contraction of guinea pig ureter, suggesting that the smooth muscle contraction is not NK1-mediated. CP-96,345 exhibited analgesic activity in acetic acid-induced abdominal stretching in mice, indicating for the first time that SP plays a critical role in this model. The results of these studies support a pathophysiological role of SP and the NK1 receptor under acute neurogenic inflammatory conditions and in pain.
引用
收藏
页码:191 / 195
页数:5
相关论文
共 25 条
[1]   MODULATION OF NEUROGENIC INFLAMMATION - NOVEL APPROACHES TO INFLAMMATORY DISEASE [J].
BARNES, PJ ;
BELVISI, MG ;
ROGERS, DF .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (05) :185-189
[2]  
BARNES PJ, 1986, LANCET, V1, P242
[3]  
BEVAN S, 1990, TRENDS PHARMACOL SCI, V11, P330
[4]  
CONSTANTINE JW, 1991, N-S ARCH PHARMACOL, V344, P471
[5]   COLONIC SUBSTANCE-P LEVELS ARE INCREASED IN ULCERATIVE-COLITIS AND DECREASED IN CHRONIC SEVERE CONSTIPATION [J].
GOLDIN, E ;
KARMELI, F ;
SELINGER, Z ;
RACHMILEWITZ, D .
DIGESTIVE DISEASES AND SCIENCES, 1989, 34 (05) :754-757
[6]   CAPSAICIN INDUCED RELEASE OF MULTIPLE TACHYKININS (SUBSTANCE-P, NEUROKININ-A AND ELEDOISIN-LIKE MATERIAL) FROM GUINEA-PIG SPINAL-CORD AND URETER [J].
HUA, XY ;
SARIA, A ;
GAMSE, R ;
THEODORSSONNORHEIM, E ;
BRODIN, E ;
LUNDBERG, JM .
NEUROSCIENCE, 1986, 19 (01) :313-319
[7]   ANALYSIS OF TACHYKININ BINDING-SITE INTERACTIONS USING CONSTRAINED ANALOGS OF TACHYKININS [J].
LAVIELLE, S ;
CHASSAING, G ;
PLOUX, O ;
LOEUILLET, D ;
BESSEYRE, J ;
JULIEN, S ;
MARQUET, A ;
CONVERT, O ;
BEAUJOUAN, JC ;
TORRENS, Y ;
BERGSTROM, L ;
SAFFROY, M ;
GLOWINSKI, J .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (01) :41-49
[8]  
LEMBECK F, 1979, N-S ARCH PHARMACOL, V310, P175, DOI 10.1007/BF00500282
[9]   THE NONPEPTIDE TACHYKININ ANTAGONIST, CP-96,345, IS A POTENT INHIBITOR OF NEUROGENIC INFLAMMATION [J].
LEMBECK, F ;
DONNERER, J ;
TSUCHIYA, M ;
NAGAHISA, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (03) :527-530
[10]  
LEMBECK F, 1987, SUBSTANCE P NEUROKIN, P380